Physician
Julien-Banica, Jehanne
Julien-Banica, Jehanne was paid $212K by Medicaid between Jul 2018 and Sep 2024, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoJULIEN-BANICA, JEHANNE
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1164653010assigned 07/27/2009
33bProvider typeFamily Medicine Physician
28Total paid$212K
24GClaims2,131
24DCodes billed7
24AFirst – last monthJul 2018 – Sep 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#393 of 2,605
Median peer was paid$10K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13 | $275.81 | |
| 2019 | 279 | $21K | |
| 2020 | 213 | $20K | |
| 2021 | 560 | $62K | |
| 2022 | 731 | $84K | |
| 2023 | 267 | $22K | |
| 2024incomplete | 68 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 989 | 981 | $76K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 24% | 379 | 377 | $50K |
| S9083 | Global fee urgent care centers | 23% | 328 | 325 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 377 | 373 | $35K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 21 | 21 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 22 | 22 | $525.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15 | 15 | $456.17 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.